Congress quietly expands hearing aid access for middle-income Americans

What it does

This bill creates a federal tax credit allowing individuals to deduct up to $1,000 per year from their taxes for the cost of purchasing hearing aids, but only if their income is below $150,000–$300,000 (depending on filing status) and they haven't claimed the credit in the prior four years. The credit applies only to FDA-approved hearing aids and cannot be combined with other tax benefits for the same expense.

Why we flagged it

The bill's core mechanism is a targeted tax credit designed to reduce financial barriers to hearing aid purchase for middle-income individuals. It is a straightforward public-health subsidy delivered through the tax code, with no hidden provisions or narrow carve-outs.

What the text implies

• The five-year election cycle may create administrative friction; individuals must actively claim the credit and cannot do so in consecutive years, potentially leaving some eligible taxpayers unaware or unable to time purchases optimally.
• The credit is capped at $1,000 annually but hearing aids often cost $2,000–$6,000 per pair; the credit covers only partial cost, leaving significant out-of-pocket burden for lower-income beneficiaries near the income cap.
• Dependents (children, adults) can benefit through a taxpayer's deduction, but only if the taxpayer claims them as a dependent; this may exclude some hearing-aid users whose family structure does not align with tax-code dependency rules.
• The bill does not address insurance coverage gaps or Medicare/Medicaid hearing aid benefits; it is a tax-code intervention that may duplicate or conflict with existing public-health programs in some states.

Who it affects

Hearing aids are expensive medical devices (typically $2,000–$6,000 per pair) that many seniors and working-age people with hearing loss cannot afford. This tax credit directly reduces out-of-pocket costs for middle-income households, improving access to a health intervention that enhances quality of life, employment prospects, and social participation. The income caps ensure the benefit targets those most likely to need assistance.

Who stands to gain

• hearing aid manufacturers and distributors
• audiology practices and hearing aid retailers

Named in the bill

Internal Revenue Code, FDA (Federal Food, Drug, and Cosmetic Act), Code of Federal Regulations (21 CFR 874.3300, 874.3305), hearing aid industry

Where it stands

2 cosponsors: 1 Democrats, 1 Republicans.

• Mar 3, 2026 — Introduced · Congress.gov: “Introduced in House”
• Mar 3, 2026 — Referred to House Committee on Ways and Means · Congress.gov: “Referred to the House Committee on Ways and Means”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $50,000 in lobbying spend. A filing names 3 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Kevin Mullin, the sponsor, reported $505,911 in PAC receipts in the 2026 cycle.

• Hearing Industries Association — $50,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.